Jill C. Rubinstein, Ph.D. - Publications

Affiliations: 
2010 Yale University, New Haven, CT 
Area:
Bioinformatics Biology, Oncology

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Rubinstein JC, Nicolson NG, Rottmann D, Morotti R, Korah R, Carling T, Christison-Lagay ER. Choice of control tissue impacts designation of germline variants in a cohort of papillary thyroid carcinoma patients. Annals of Oncology. 31: 815-821. PMID 32165204 DOI: 10.1016/J.Annonc.2020.02.013  0.404
2019 Rubinstein JC, Khan SA, Christison-Lagay ER, Cha C. APC Mutational Patterns in Gastric Adenocarcinoma are Enriched for Missense Variants with Associated Decreased Survival. Genes, Chromosomes & Cancer. PMID 31353684 DOI: 10.1002/Gcc.22792  0.341
2019 Rubinstein JC, Nicolson NG, Ahuja N. Next-generation Sequencing in the Management of Gastric and Esophageal Cancers. The Surgical Clinics of North America. 99: 511-527. PMID 31047039 DOI: 10.1016/J.Suc.2019.02.005  0.365
2018 Brown TC, Murtha TD, Rubinstein JC, Korah R, Carling T. SLC12A7 alters adrenocortical carcinoma cell adhesion properties to promote an aggressive invasive behavior. Cell Communication and Signaling : Ccs. 16: 27. PMID 29884238 DOI: 10.1186/S12964-018-0243-0  0.33
2017 Rubinstein JC, Majumdar SK, Laskin W, Lazaga F, Prasad ML, Carling T, Khan SA. Hyperparathyroidism-Jaw Tumor Syndrome Associated With Large-Scale 1q31 Deletion. Journal of the Endocrine Society. 1: 926-930. PMID 29264543 DOI: 10.1210/Js.2016-1089  0.36
2016 Rubinstein JC, Brown TC, Christison-Lagay ER, Zhang Y, Kunstman JW, Juhlin CC, Nelson-Williams C, Goh G, Quinn CE, Callender GG, Udelsman R, Lifton RP, Korah R, Carling T. Shifting patterns of genomic variation in the somatic evolution of papillary thyroid carcinoma. Bmc Cancer. 16: 646. PMID 27538953 DOI: 10.1186/S12885-016-2665-7  0.359
2015 Brown TC, Juhlin CC, Healy JM, Stenman A, Rubinstein JC, Korah R, Carling T. DNA copy amplification and overexpression of SLC12A7 in adrenocortical carcinoma. Surgery. PMID 26454676 DOI: 10.1016/J.Surg.2015.08.038  0.397
2015 Rubinstein JC, Brown TC, Goh G, Juhlin CC, Stenman A, Korah R, Carling T. Chromosome 19 amplification correlates with advanced disease in adrenocortical carcinoma. Surgery. PMID 26453132 DOI: 10.1016/J.Surg.2015.09.001  0.397
2015 Juhlin CC, Stenman A, Haglund F, Clark VE, Brown TC, Baranoski J, Bilguvar K, Goh G, Welander J, Svahn F, Rubinstein JC, Caramuta S, Yasuno K, Günel M, Bäckdahl M, et al. Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene. Genes, Chromosomes & Cancer. 54: 542-54. PMID 26032282 DOI: 10.1002/Gcc.22267  0.33
2015 Kunstman JW, Juhlin CC, Goh G, Brown TC, Stenman A, Healy JM, Rubinstein JC, Choi M, Kiss N, Nelson-Williams C, Mane S, Rimm DL, Prasad ML, Höög A, Zedenius J, et al. Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing. Human Molecular Genetics. 24: 2318-29. PMID 25576899 DOI: 10.1093/Hmg/Ddu749  0.357
2014 Rubinstein JC, Visa A, Zhang L, Antonescu CR, Christison-Lagay ER, Morotti R. Primary low-grade fibromyxoid sarcoma of the kidney in a child with the alternative EWSR1-CREB3L1 gene fusion. Pediatric and Developmental Pathology : the Official Journal of the Society For Pediatric Pathology and the Paediatric Pathology Society. 17: 321-6. PMID 24896634 DOI: 10.2350/14-05-1487-Cr.1  0.351
2010 Rubinstein JC, Tran N, Ma S, Halaban R, Krauthammer M. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma. Bmc Medical Genomics. 3: 4. PMID 20144234 DOI: 10.1186/1755-8794-3-4  0.487
2009 Szpakowski S, Sun X, Lage JM, Dyer A, Rubinstein J, Kowalski D, Sasaki C, Costa J, Lizardi PM. Loss of epigenetic silencing in tumors preferentially affects primate-specific retroelements. Gene. 448: 151-67. PMID 19699787 DOI: 10.1016/J.Gene.2009.08.006  0.418
Show low-probability matches.